Article: The pharmacologic management of insomnia in patients with HIV.
2009 Volume 5, Issue 3, Page(s) 251–262
Abstract: Insomnia is common in human immunodeficiency virus (HIV) seropositive populations. Some studies have estimated as many as 70% of HIV patients experience insomnia at some point during their illness. Insomnia has been linked to reduced quality of life as ... ...
| Abstract | Insomnia is common in human immunodeficiency virus (HIV) seropositive populations. Some studies have estimated as many as 70% of HIV patients experience insomnia at some point during their illness. Insomnia has been linked to reduced quality of life as well as treatment non-adherence in these patients. However, there has been very limited research on the treatment of insomnia in this setting. Lacking treatment trials, we carried out a review of the available literature relevant to the pharmacologic treatment of insomnia in HIV seropositive individuals in order to provide guidance for the clinical management of this complex population. A systematic MEDLINE search was performed using as search terms each of the FDA approved or commonly prescribed insomnia medications and "insomnia and HIV." In addition, we reviewed the published literature on HIV therapies and common comorbid conditions and their interactions with insomnia therapies. We found 4 primary factors affecting the pharmacotherapy of insomnia in individuals with HIV: (1) medications used to treat HIV; (2) antibiotics used to treat opportunistic infections; (3) the HIV infection itself; and (4) conditions frequently associated with HIV infection. The means by which these factors affect the expected risk-benefit profile of insomnia therapies is discussed, and recommendations are made for choosing medications in patients encountered in clinical practice. |
|---|---|
| MeSH term(s) | Anti-Bacterial Agents/therapeutic use ; Antidepressive Agents/therapeutic use ; Antipsychotic Agents/therapeutic use ; Benzodiazepines/therapeutic use ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Hypnotics and Sedatives/therapeutic use ; Sleep Initiation and Maintenance Disorders/drug therapy ; Sleep Initiation and Maintenance Disorders/etiology |
| Chemical Substances | Anti-Bacterial Agents ; Antidepressive Agents ; Antipsychotic Agents ; Hypnotics and Sedatives ; Benzodiazepines (12794-10-4) |
| Language | English |
| Publishing date | 2009-12-04 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 2397213-0 |
| ISSN | 1550-9389 |
| ISSN | 1550-9389 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6590: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.